2020
DOI: 10.1007/978-981-15-1671-9_22
|View full text |Cite
|
Sign up to set email alerts
|

Circulating Non-coding RNAs and Cardiovascular Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 95 publications
0
9
0
Order By: Relevance
“…This review focuses on regulatory noncoding RNAs that are directly or indirectl responsive to flow and their involvement with cardiovascular effects of altered bloo flow, with a focus on the potential clinical relevance and the underlying molecular mech anisms and their possible use as clinical biomarkers [71]. As relevant evidence is no equally available for all ncRNAs sub-categories, some specific ncRNAs, including siR NAs, snoRNA or piRNA are not mentioned in this review due to lack of evidence in rela Noncoding RNAs are largely involved in cardiovascular physiology, atherosclerosis [35], and multiple cardiovascular diseases [36], as chronic and acute coronary syndromes [6,[37][38][39][40][41], vascular remodeling [29,42], valvular heart disease [43][44][45][46][47], generation and progression of ectopic calcifications in the cardiovascular system [48][49][50][51][52][53][54], platelet function [55][56][57][58][59], heart failure and stroke [60][61][62][63][64][65][66][67][68][69][70].…”
Section: Noncoding Rnasmentioning
confidence: 99%
See 1 more Smart Citation
“…This review focuses on regulatory noncoding RNAs that are directly or indirectl responsive to flow and their involvement with cardiovascular effects of altered bloo flow, with a focus on the potential clinical relevance and the underlying molecular mech anisms and their possible use as clinical biomarkers [71]. As relevant evidence is no equally available for all ncRNAs sub-categories, some specific ncRNAs, including siR NAs, snoRNA or piRNA are not mentioned in this review due to lack of evidence in rela Noncoding RNAs are largely involved in cardiovascular physiology, atherosclerosis [35], and multiple cardiovascular diseases [36], as chronic and acute coronary syndromes [6,[37][38][39][40][41], vascular remodeling [29,42], valvular heart disease [43][44][45][46][47], generation and progression of ectopic calcifications in the cardiovascular system [48][49][50][51][52][53][54], platelet function [55][56][57][58][59], heart failure and stroke [60][61][62][63][64][65][66][67][68][69][70].…”
Section: Noncoding Rnasmentioning
confidence: 99%
“…This review focuses on regulatory noncoding RNAs that are directly or indirectly responsive to flow and their involvement with cardiovascular effects of altered blood flow, with a focus on the potential clinical relevance and the underlying molecular mechanisms and their possible use as clinical biomarkers [71]. As relevant evidence is not equally available for all ncRNAs sub-categories, some specific ncRNAs, including siRNAs, snoRNA or piRNA are not mentioned in this review due to lack of evidence in relation to flow conditions.…”
Section: Noncoding Rnasmentioning
confidence: 99%
“…Noncoding RNAs (ncRNAs) are considered major players in physiological and pathological processes based on their versatile regulatory roles in different diseases, including cardiovascular disease. [5,6] Circular RNAs (circRNAs) are a subtype of endogenous ncRNAs, constitute a substantial fraction of the mammalian transcriptome, [7] and are abundantly expressed in the cardiovascular system. [8,9] The circRNAs that function as competing endogenous RNA (ceRNA) have been most extensively studied in I/R injury.…”
Section: Introductionmentioning
confidence: 99%
“…Circulating miRNAs are associated with vesicles (exosomes, microparticles and apoptotic bodies), protein complexes (Ago2, NPM1) and lipoprotein complexes (HDL, LDL complexes) 7,8 . Circulating miRNAs are regarded as promising noninvasive biomarkers for risk stratification, diagnosis and prognosis of various cardiometabolic diseases 9–12 . In addition, circulating miRNAs are mediators of intercellular signalling 13 .…”
Section: Introductionmentioning
confidence: 99%
“…7,8 Circulating miRNAs are regarded as promising noninvasive biomarkers for risk stratification, diagnosis and prognosis of various cardiometabolic diseases. [9][10][11][12] In addition, circulating miRNAs are mediators of intercellular signalling. 13 It has been proposed that circulating miRNAs behave like hormones in intercellular communications.…”
mentioning
confidence: 99%